Edwards' pharma attack used bogus stats

When John Edwards knocked drug companies for spending "twice as much" on marketing and administration as on research, he perpetuated a myth popular amongst pharma naysayers, Fortune magazine says. With only 21 percent of Americans approving Big Pharma's performance (down from 60 percent 10 years ago), it's no wonder people are ready to believe.

The erroneous stat? Lumping marketing and admin together. That line item doesn't really show how much companies spend on selling their products. It includes stuff like office leases, for example. The real numbers, Fortune says? Drug makers spent $55 billion on research in 2006, compared with $12 billion on sales, promotions, and ads.

- read the report in Fortune

Related Articles:
Edwards pledges limits on DTC ads. Report
Final FDA bill lacks new DTC oversight. Report
10 reforms for drug advertising. Report
Does the FDA do enough to regulate drug ads? Report

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.